MedTrace Logo

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

NCT03138837 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 385

Last updated 2017-05-17

No results posted yet for this study

Summary

assess diagnostic performance of 3-Tesla DW-MRI in detecting and staging bladder cancer and potential role of the ADC value as a biomarker reflecting histological grade and stage.

Conditions

  • Bladder Cancer
  • Diagnoses Disease
  • Magnetic Resonance Imaging
  • Apparent Diffusion Coefficient

Interventions

DIAGNOSTIC_TEST

Magnetic resonance imaging

Diffusion Weighted Magnetic resonance imaging

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Hassan Abol-Enein, MD · Urology and Nephrology center

  • Mohamed AboElghar, MD · Urology and Nephrology center

  • Ahmed O. Mosbah, MD · Urology and Nephrology center

  • Khaled Sheir, MD · Urology and Nephrology center

  • Ahmed Elassmy, MD · Urology and Nephrology center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03138837 on ClinicalTrials.gov